+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Disease Modalities & Software Market - Global Forecast 2025-2030- Product Image
Brain Disease Modalities & Software Market - Global Forecast 2025-2030- Product Image
Sale

Brain Disease Modalities & Software Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011105
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brain Disease Modalities & Software Market is experiencing a period of significant transformation, driven by rapid technological advancement, evolving clinical needs, and the growing demand for precision diagnostics. Senior executives are turning to integrated diagnostic and software solutions to streamline care pathways, improve outcomes, and maintain a competitive edge in a landscape shaped by innovation and increasing complexity.

Market Snapshot: Brain Disease Modalities & Software Market

The Brain Disease Modalities & Software Market grew from USD 16.11 billion in 2024 to USD 16.98 billion in 2025. It is expected to continue growing at a CAGR of 5.21%, reaching USD 21.86 billion by 2030. This growth reflects the market’s responsiveness to heightened clinical demand for early brain disease detection, the integration of multimodal imaging, and the rising importance of software-driven decision support across global healthcare systems.

Scope & Segmentation

  • Imaging Modality: Computed tomography (conventional and spectral), electroencephalography (ambulatory and routine), magnetic resonance imaging (structural, functional, and diffusion tensor), magnetoencephalography (resting state, evoked response), positron emission tomography (amyloid and FDG tracers), high-resolution ultrasound, and transcranial Doppler.
  • Software Type: AI-based tools (deep learning, machine learning), clinical decision support, diagnostic suites (image analysis, segmentation), monitoring software (neurophysiological, remote patient), telehealth platforms, and workflow management.
  • Disease Indication: Alzheimer’s, multiple sclerosis, epilepsy (focal and generalized), Parkinson’s, stroke (ischemic and hemorrhagic), and traumatic brain injury (mild and severe).
  • End User: Ambulatory surgical centers, diagnostic imaging centers, neurology and rehabilitation clinics, private and public hospitals, and research institutes.
  • Deployment Mode: Cloud-based, hybrid, on-premise.
  • Distribution Channel: Direct sales, distributors, and online platforms.
  • Regional Coverage: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe (United Kingdom, Germany, France, and others), Middle East & Africa (including UAE, Saudi Arabia, South Africa), and Asia-Pacific (driven by China, India, Japan, and key ASEAN markets).
  • Leading Companies Profiled: Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi, Ltd., Brainlab AG, Elekta AB (publ), Medtronic plc, Stryker Corporation, IBM Corporation.

Key Takeaways

  • Integration of advanced imaging and analytical software is reshaping diagnostic workflows for neurodegenerative and acute neurological disorders, supporting more personalized treatment strategies.
  • Collaboration among radiologists, neurologists, engineers, and software developers is accelerating the development of integrated platforms that streamline data acquisition, analysis, and clinical decision support.
  • Cloud-native architectures and edge computing are expanding access to sophisticated tools, especially in remote or underserved regions, while maintaining high standards of data security.
  • Regulatory harmonization, especially in Europe, is raising quality benchmarks and promoting robust clinical validation and post-market surveillance for new solutions.
  • Hybrid deployment models and flexible workflow management are enabling healthcare providers to adapt rapidly to shifts in demand while optimizing resource allocation and reporting efficiency.
  • Strategic alliances across the value chain, from OEMs to research institutes, are playing a critical role in accelerating innovation and market adoption.

Tariff Impact

The introduction of revised United States tariffs in 2025 has affected global supply chains, particularly for imported diagnostic instrumentation and electronic components. This has led equipment suppliers to reassess procurement channels, prompting increased interest in local manufacturing and optimized production strategies. Software providers are responding by streamlining algorithms to function efficiently on cost-effective hardware, and healthcare organizations are increasingly evaluating deployment with regional cloud partners to mitigate volatility.

Methodology & Data Sources

This report utilizes a mixed-methods approach, drawing on in-depth expert interviews, structured provider and vendor surveys, regulatory filings, clinical trial registries, peer-reviewed literature, and corporate white papers. Data triangulation and validation workshops with industry experts ensure accuracy and actionable insight.

Why This Report Matters

  • Equips decision-makers with a clear framework to anticipate trends and develop strategies aligned to technological, regulatory, and commercial realities.
  • Supports investment and partnership decision-making by illuminating risks and opportunities across modalities, software types, and regional markets.
  • Enables organizations to enhance diagnostic accuracy, operational efficiency, and regulatory compliance through evidence-based recommendations.

Conclusion

The sustained progress in imaging modalities and intelligent software is reshaping brain disease diagnostics worldwide. By leveraging these insights, senior leaders can set a course for improved patient outcomes and durable growth within a high-stakes landscape defined by ongoing innovation and collaboration.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of cloud-based neuroimaging analytics platforms integrating multimodal MRI and PET data for real-time diagnostic insights
5.2. Integration of wearable biosensors with AI-powered platforms to monitor Parkinson’s disease motor fluctuations continuously
5.3. Deployment of tele-neurology software solutions enabling remote EEG monitoring and virtual consultations for stroke rehabilitation
5.4. Advancements in multiplexed biomarker assays for personalized treatment planning in multiple sclerosis therapies
5.5. Emergence of blockchain-enabled brain health data management systems ensuring secure interoperability among research centers
5.6. Growth of subscription-based SaaS neurodiagnostic tools offering predictive analytics for early Alzheimer’s disease risk assessment
5.7. Regulatory approvals accelerating commercialization of AI-driven PET imaging software for quantitative oncological brain lesion analysis
5.8. Development of VR-based cognitive rehabilitation programs integrated with cloud telemetry to personalize stroke recovery protocols
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Disease Modalities & Software Market, by Imaging Modality
8.1. Introduction
8.2. Computed Tomography
8.2.1. Conventional Ct
8.2.2. Spectral Ct
8.3. Electroencephalography
8.3.1. Ambulatory Eeg
8.3.2. Routine Eeg
8.4. Magnetic Resonance Imaging
8.4.1. Diffusion Tensor Imaging
8.4.2. Functional Mri
8.4.3. Structural Mri
8.5. Magnetoencephalography
8.5.1. Evoked Response
8.5.2. Resting State
8.6. Positron Emission Tomography
8.6.1. Amyloid Pet
8.6.2. Fdg Pet
8.7. Ultrasound
8.7.1. High Resolution
8.7.2. Transcranial Doppler
9. Brain Disease Modalities & Software Market, by Software Type
9.1. Introduction
9.2. Ai Based Software
9.2.1. Deep Learning Algorithms
9.2.2. Machine Learning Algorithms
9.3. Clinical Decision Support Software
9.4. Diagnostic Software
9.4.1. Image Analysis Software
9.4.2. Segmentation Software
9.5. Monitoring Software
9.5.1. Neurophysiological Monitoring
9.5.2. Remote Patient Monitoring
9.6. Telehealth Platform
9.7. Workflow Management Software
10. Brain Disease Modalities & Software Market, by Disease Indication
10.1. Introduction
10.2. Alzheimer's Disease
10.3. Epilepsy
10.3.1. Focal Onset
10.3.2. Generalized Onset
10.4. Multiple Sclerosis
10.5. Parkinson's Disease
10.6. Stroke
10.6.1. Hemorrhagic Stroke
10.6.2. Ischemic Stroke
10.7. Traumatic Brain Injury
10.7.1. Mild Tbi
10.7.2. Severe Tbi
11. Brain Disease Modalities & Software Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.3.1. Neurology Clinics
11.3.2. Rehabilitation Clinics
11.4. Diagnostic Imaging Centers
11.5. Hospitals
11.5.1. Private Hospitals
11.5.2. Public Hospitals
11.6. Research Institutes
12. Brain Disease Modalities & Software Market, by Deployment Mode
12.1. Introduction
12.2. Cloud Based
12.3. Hybrid
12.4. On Premise
13. Brain Disease Modalities & Software Market, by Distribution Channel
13.1. Introduction
13.2. Direct
13.3. Distributors
13.4. Online Platforms
14. Americas Brain Disease Modalities & Software Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Brain Disease Modalities & Software Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Brain Disease Modalities & Software Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Siemens Healthineers AG
17.3.2. GE HealthCare Technologies Inc.
17.3.3. Koninklijke Philips N.V.
17.3.4. Canon Medical Systems Corporation
17.3.5. Hitachi, Ltd.
17.3.6. Brainlab AG
17.3.7. Elekta AB (publ)
17.3.8. Medtronic plc
17.3.9. Stryker Corporation
17.3.10. IBM Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BRAIN DISEASE MODALITIES & SOFTWARE MARKET: RESEARCHAI
FIGURE 28. BRAIN DISEASE MODALITIES & SOFTWARE MARKET: RESEARCHSTATISTICS
FIGURE 29. BRAIN DISEASE MODALITIES & SOFTWARE MARKET: RESEARCHCONTACTS
FIGURE 30. BRAIN DISEASE MODALITIES & SOFTWARE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SPECTRAL CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ROUTINE EEG, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ROUTINE EEG, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STRUCTURAL MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STRUCTURAL MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EVOKED RESPONSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EVOKED RESPONSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESTING STATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESTING STATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMYLOID PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMYLOID PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FDG PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FDG PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEEP LEARNING ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEEP LEARNING ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEGMENTATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEGMENTATION SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROPHYSIOLOGICAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROPHYSIOLOGICAL MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TELEHEALTH PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TELEHEALTH PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FOCAL ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FOCAL ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GENERALIZED ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GENERALIZED ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MILD TBI, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MILD TBI, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEVERE TBI, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEVERE TBI, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REHABILITATION CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REHABILITATION CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 249. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 250. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 251. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 252. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 253. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 254. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 255. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 256. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 257. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
TABLE 258. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2025-2030 (USD MILLION)
TABLE 259. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 260. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 261. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 262. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 263. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
TABLE 264. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2025-2030 (USD MILLION)
TABLE 265. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2024 (USD MILLION)
TABLE 266. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2025-2030 (USD MILLION)
TABLE 267. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2024 (USD MILLION)
TABLE 268. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2025-2030 (USD MILLION)
TABLE 269. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2024 (USD MILLION)
TABLE 270. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2025-2030 (USD MILLION)
TABLE 271. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 272. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 273. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 274. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 275. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
TABLE 276. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
TABLE 277. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2024 (USD MILLION)
TABLE 278. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2025-2030 (USD MILLION)
TABLE 279. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Brain Disease Modalities & Software market report include:
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Hitachi, Ltd.
  • Brainlab AG
  • Elekta AB (publ)
  • Medtronic plc
  • Stryker Corporation
  • IBM Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.98 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.86 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

4D Medical Imaging Software Market - Global Forecast 2025-2030 - Product Image

4D Medical Imaging Software Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2025-2030 - Product Image

AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030 - Product Image

Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030

  • Report
  • 465 Pages
  • Global
From
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029 - Product Image

Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029

  • Report
  • 249 Pages
  • Global
From
Stroke Post Processing Software Market Size, Share & Trends Analysis Report By Installation, By Modality (MRI, and CT Scan), By Type, By End-use, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Stroke Post Processing Software Market Size, Share & Trends Analysis Report By Installation, By Modality (MRI, and CT Scan), By Type, By End-use, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 290 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.